These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11329838)

  • 21. Bayeswatch: an overview of Bayesian statistics.
    Austin PC; Brunner LJ; Hux JE
    J Eval Clin Pract; 2002 May; 8(2):277-86. PubMed ID: 12060417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bayesian Analyses of Cardiovascular Trials-Bringing Added Value to the Table.
    Brophy JM
    Can J Cardiol; 2021 Sep; 37(9):1415-1427. PubMed ID: 33775879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revolutionizing Estimation and Inference for Program Evaluation Using Bayesian Methods.
    Vollmer L; Finucane M; Brown R
    Eval Rev; 2020 Aug; 44(4):295-324. PubMed ID: 30537865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Count on your beliefs. Bayes--not the P value--measures credence].
    Taube A; Malmquist J
    Lakartidningen; 2001 Jul; 98(28-29):3208-11. PubMed ID: 11496808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting engagement between academic faculty and decision-makers: learnings and priorities for a school of public health.
    Jessani NS; Siddiqi SM; Babcock C; Davey-Rothwell M; Ho S; Holtgrave DR
    Health Res Policy Syst; 2018 Jul; 16(1):65. PubMed ID: 30045730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bridging the gap between statistical analysis and decision making in public health research.
    Stangl DK
    Stat Med; 2005 Feb; 24(4):503-11. PubMed ID: 15678414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian methodology for the design and interpretation of clinical trials in critical care medicine: a primer for clinicians.
    Kalil AC; Sun J
    Crit Care Med; 2014 Oct; 42(10):2267-77. PubMed ID: 25226118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian versus Frequentist statistical modeling: a debate for hit selection from HTS campaigns.
    Cloutier LM; Sirois S
    Drug Discov Today; 2008 Jun; 13(11-12):536-42. PubMed ID: 18549981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using Bayesian modeling in frequentist adaptive enrichment designs.
    Simon N; Simon R
    Biostatistics; 2018 Jan; 19(1):27-41. PubMed ID: 28520893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Bayesian approach to stochastic cost-effectiveness analysis. An illustration and application to blood pressure control in type 2 diabetes.
    Briggs AH
    Int J Technol Assess Health Care; 2001; 17(1):69-82. PubMed ID: 11329846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MOST IMPORTANT BARRIERS AND FACILITATORS REGARDING THE USE OF HEALTH TECHNOLOGY ASSESSMENT.
    Cheung KL; Evers SMAA; de Vries H; Hiligsmann M
    Int J Technol Assess Health Care; 2017 Jan; 33(2):183-191. PubMed ID: 28849758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Where's the utility in Bayesian data-monitoring of clinical trials?
    Ashby D; Tan SB
    Clin Trials; 2005; 2(3):197-205; discussion 205-8. PubMed ID: 16279143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian designs and the control of frequentist characteristics: a practical solution.
    Ventz S; Trippa L
    Biometrics; 2015 Mar; 71(1):218-226. PubMed ID: 25196832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Informed decision-making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments.
    Weir CJ; Taylor RS
    Pharm Stat; 2022 Jul; 21(4):740-756. PubMed ID: 35819121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.
    Tunis SR; Stryer DB; Clancy CM
    JAMA; 2003 Sep; 290(12):1624-32. PubMed ID: 14506122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Web-based Bayesian Communication: the Bayesian z-test.
    Lehmann HP; Barshay A; Grimm L; Robinson KA; Sheffield C
    AMIA Annu Symp Proc; 2005; 2005():1023. PubMed ID: 16779310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of economic evidence in Canadian oncology reimbursement decision-making: to lambda and beyond.
    Rocchi A; Menon D; Verma S; Miller E
    Value Health; 2008; 11(4):771-83. PubMed ID: 18179658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Bayesian paradigm for decision-making in proof-of-concept trials.
    Pulkstenis E; Patra K; Zhang J
    J Biopharm Stat; 2017; 27(3):442-456. PubMed ID: 28166459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.